Health Care & Life Sciences » Biotechnology | Arrowhead Pharmaceuticals Corp.

Arrowhead Pharmaceuticals Corp.

Arrowhead Pharmaceuticals Corp.
Stock Exchange NASDAQ Stock Market
EPS
$0.07
Market Cap
$2.52 B
Shares Outstanding
94.81 M
Public Float
81.6 M

Profile

Address
225 South Lake Avenue
Pasadena California 91101
United States
Employees -
Website http://www.arrowheadpharma.com
Updated 07/08/2019
Arrowhead Pharmaceuticals, Inc. engages as a biopharmaceutical company developing targeted RNAi therapeutics. Its pipeline includes clinical programs in chronic hepatitis B virus and partner based programs in obesity and oncology. The company was founded by R.

Financials

View All

Douglass B. Given
Chairman
Christopher Richard Anzalone
President, Chief Executive Officer & Director